Stockscreener 앱 받기
0.9201
0.51%
0.0047
시간 외 거래:
.94
0.0199
+2.16%
Inflarx N V 주식(IFRX)의 최신 뉴스
Analysts Set InflaRx N.V. (NASDAQ:IFRX) Target Price at $7.50 - Defense World
IFRX Earnings History & Surprises | EPS & Revenue Results | INFLARX NV (NASDAQ:IFRX) - ChartMill
Aug Macro: Whats the analyst consensus on InflaRx NV2025 Market Sentiment & Community Consensus Stock Picks - baoquankhu1.vn
InflaRx N.V. (NASDAQ:IFRX) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
InflaRx Announces Participation in the Leerink Partners Global Healthcare Conference - Bitget
Biotech InflaRx to stream March 9 Leerink healthcare fireside chat - Stock Titan
InflaRx Showcases Izicopan HS and CSU Data, Streamlines C5aR Strategy at Oppenheimer Conference - MarketBeat
InflaRx N.V. (IFRX) Presents at Oppenheimer 36th Annual Healthcare Life Sciences ConferenceSlideshow - Seeking Alpha
IFRX Should I Buy - Intellectia AI
IFRX PE Ratio & Valuation, Is IFRX Overvalued - Intellectia AI
InflaRx Spotlights Izicopan HS Data, Phase 2b Plans and 30% Cost Cuts at Guggenheim Summit - MarketBeat
IFRX Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Will InflaRx N.V. stock continue dividend increasesJuly 2025 Snapshot & Long-Term Safe Investment Ideas - mfd.ru
Is InflaRx N.V. (IF0) stock among top earnings playsPortfolio Update Summary & Growth Oriented Trading Recommendations - mfd.ru
Treasury Yields: Is InflaRx NV forming bullish engulfing patternsEarnings Risk Summary & Smart Investment Allocation Tips - baoquankhu1.vn
InflaRx N.V. (NASDAQ:IFRX) Receives $7.50 Consensus PT from Analysts - Defense World
Here's Why We're A Bit Worried About InflaRx's (NASDAQ:IFRX) Cash Burn Situation - Sahm
InflaRx N.V. (NASDAQ:IFRX) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
InflaRx launches public offering of shares and warrants - MSN
How strong is InflaRx N.V. stock revenue growthWeekly Profit Report & Growth Oriented Trading Recommendations - mfd.ru
InflaRx (NASDAQ:IFRX) Trading 10.4% HigherStill a Buy? - MarketBeat
Here's Why InflaRx (NASDAQ:IFRX) Must Use Its Cash Wisely - Yahoo Finance
History Review: Is InflaRx NV showing insider buyingWeekly Risk Report & Safe Swing Trade Setups - baoquankhu1.vn
Tech Rally: Can InflaRx NV sustain earnings growth2025 EndofYear Setup & Daily Technical Stock Forecast Reports - baoquankhu1.vn
InflaRx Announces Participation in February Investor Conferences - marketscreener.com
Can InflaRx N.V. deliver consistent dividendsTrade Risk Summary & Weekly Market Pulse Alerts - mfd.ru
Biotech firm InflaRx lines up two investor talks in February - Stock Titan
InflaRx NV Explodes After FDA Greenlight: Is IFRX the Biotech Underdog You’re Sleeping On? - AD HOC NEWS
Buyback Watch: Is InflaRx NV showing insider buyingJuly 2025 Levels & Real-Time Market Sentiment Alerts - baoquankhu1.vn
Can InflaRx N.V. (IF0) stock sustain margin levelsMarket Performance Recap & Technical Analysis for Trade Confirmation - bollywoodhelpline.com
Is InflaRx N.V. stock positioned for digital transformationMarket Movers & Safe Entry Point Identification - bollywoodhelpline.com
Meme Stocks: Can InflaRx NV deliver consistent dividends2025 Pullback Review & Safe Entry Momentum Stock Tips - baoquankhu1.vn
Bank Watch: Is Montauk Renewables Inc a potential multi baggerWatch List & Low Drawdown Momentum Ideas - baoquankhu1.vn
Biotech Update: IFRX, ABCL, RLYB Stand Out as Significant Gainers After Hours - Intellectia AI
Bull Run: Why InflaRx N.V. (IF0) stock could rally stronglyJuly 2025 Levels & Weekly High Potential Stock Alerts - Bộ Nội Vụ
InflaRx N.V. (NASDAQ:IFRX) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World
Pullback Watch: Will InflaRx NV stock recover faster than market2025 Key Highlights & Daily Profit Maximizing Tips - Bộ Nội Vụ
Is InflaRx N.V. stock a top pick in earnings season2025 Fundamental Recap & Intraday High Probability Setup Alerts - Улправда
Why InflaRx N.V. stock remains on buy listsWeekly Investment Recap & Reliable Breakout Stock Forecasts - Улправда
How InflaRx N.V. stock valuations compare to rivalsInflation Watch & Technical Pattern Recognition Alerts - Улправда
InflaRx Cuts Workforce and Refocuses Strategy on Lead Drug Izicopan to Extend Cash Runway to 2027 - TipRanks
Will InflaRx N.V. stock recover faster than market2025 Top Gainers & Advanced Swing Trade Entry Alerts - Улправда
Why is InflaRx Stock Falling Today?InflaRx (NASDAQ:IFRX) - Benzinga
InflaRx stock falls after announcing restructuring and pipeline prioritization By Investing.com - Investing.com India
InflaRx stock falls after announcing restructuring and pipeline prioritization - Investing.com
InflaRx to prioritize izicopan development, cuts workforce by 30% - Investing.com South Africa
InflaRx Announces Strategy Focused on Capital-Efficient Execution with Izicopan and Near-Term Value Creation - GlobeNewswire
What analysts say about InflaRx NV IF0 stockPrice Support Zones & Follow Top Performers in the Community - earlytimes.in
InflaRx Reopens Case For Axed Phase 3 Drug For Rare Skin Disorder - Sahm
Weekly Buzz: ARS Pharma's Neffy Goes East, SLS Advances, A Signal Of Hope For IFRX? - RTTNews
3.69%
0.68%
자본화:
|
볼륨(24시간):